Cancer remains the leading cause of death worldwide despite advances in treatment
options for patients. As such, safe and effective therapeutics are required. Short peptides …

Peptide-and protein-based therapeutics have drawn significant attention over the past few
decades for the treatment of infectious diseases, genetic disorders, oncology, and many …

Immunomodulatory peptides are a complex class of bioactive peptides that encompasses
substances with different mechanisms of action. Immunomodulatory peptides could also be …

Cancer progression is marked by the infiltration of immunosuppressive cells, such as tumor-
associated macrophages (TAMs), regulatory T lymphocytes (Tregs), and myeloid-derived …

Cancer immunotherapies include monoclonal antibodies, cytokines, oncolytic viruses,
cellular therapies, and other biological and synthetic immunomodulators. These are …

There is a high occurrence of obesity worldwide without many new medications being
approved for its treatment. Therefore, there is an urgent need to introduce new approaches …

Bioactive peptides are released during the production of fermented dairy, vegetables, fruits,
legumes, fish, and meat products. The proteolytic specificity of lactic acid bacteria, Bacillus …

Instead of only focusing on the targeted drug delivery system, researchers have a great
interest in developing peptide‐based therapies for the procurement of numerous class of …

Bioactive peptides (BPs) are chains of amino acids linked together by peptide bonds and
arranged in a specific way. These peptides are important to human health and can be used …

The identification of the major target antigen phospholipase A2 receptor (PLA2R) in the
majority of primary (idiopathic) cases of membranous nephropathy (MN) has been followed …